New Hampshire Code of Administrative Rules
He - Department of Health and Human Services
Subtitle He-P - Former Division of Public Health Services
Chapter He-P 800 - RESIDENTIAL CARE AND HEALTH FACILITY RULES
Part He-P 827 - FREESTANDING MEGAVOLTAGE RADIATION THERAPY FACILITY
Section He-P 827.17 - Medication Services

Universal Citation: NH Admin Rules He-P 827.17

Current through Register No. 40, October 3, 2024

(a) All medications shall be made available to the patient in accordance with the written and signed orders of the licensed practitioner or other professional with prescriptive powers.

(b) All medications and treatments shall be reviewed and signed by a licensed practitioner at each visit or when indicated by a change in the patient's condition.

(1) Obtain and store any medication ordered for use at the FMRTF;

(2) Reorder medications for use at the FMRTF; and

(3) Receive and record new medication orders.

(d) Each medication order shall legibly display the following information:

(1) The patient's name;

(2) The medication name, strength, prescribed dose, and route, if different than by mouth;

(3) The frequency of administration;

(4) The indications for usage, to include the maximum allowed dose in a 24-hour period, for all medications that are used PRN; and

(5) The dated signature of the ordering practitioner as allowed by He-P 827.03(bd) .

(e) Except for pharmaceutical samples, each prescription medication container and medication record together shall collectively legibly display the following information in such a way so as to clearly identify the intended recipient:

(1) The patient's name;

(2) The medication name, strength, the prescribed dose, and route of administration;

(3) The frequency of administration;

(4) The indications for usage of all PRN medications;

(5) The date ordered;

(6) The name of the prescribing practitioner; and

(7) The expiration date of the medication(s) .

(f) Pharmaceutical samples shall be used in accordance with the licensed practitioner's written order and labeled by the licensed practitioner, the administrator, licensee, or their designee, with the patient's name, and shall be exempt from (e) (2) -(6) above.

(g) The dosage, frequency, and route of administration on the labels of all prescription medications for each patient shall be identical to the dosage, frequency, and route of administration on the facility medication record except as allowed by (i) or (j) below.

(h) The change in the dose of a medication, or the discontinuation of a medication, shall be authorized in writing by a licensed practitioner and the FMRTF shall indicate in writing, in the medication record, the date the change in dose or the discontinuance occurred.

(i) Only a pharmacist shall make changes to prescription medication container labels except as allowed by (j) below.

(j) When the licensed practitioner or other professional with prescriptive powers changes the dose and personnel are unable to obtain a new prescription label, the original container shall be clearly marked without obstructing the pharmacy label to indicate a change in the medication order.

(k) Only a licensed nurse shall accept telephone orders for medications, treatments, and therapeutic diets, and the licensed nurse shall immediately transcribe and sign the order.

(l) The transcribed order in (k) above shall be counter-signed by the authorized prescriber within 30 days of receipt.

(m) No medications shall be given to or taken by a patient until a written order is received, except as allowed by (k) and (l) above.

(n) The medication storage area for medications shall be:

(1) Locked and accessible only to authorized personnel;

(2) Clean and organized with adequate lighting to ensure correct identification of each patient's medication(s); and

(3) Equipped to maintain medication at the proper temperature.

(o) All medication at the FMRTF shall be kept in the original containers as dispensed by the pharmacy and properly closed after each use.

(p) Topical liquids, ointments, patches, creams, or powder forms of products shall be stored in such a manner that cross contamination with oral, optic, ophthalmic, and parenteral products shall not occur.

(q) If controlled substances, as defined by RSA 318-B, are stored in a central storage area in the FMRTF, they shall be kept in a separately locked compartment within the locked medication storage area accessible only to authorized personnel.

(r) The licensee shall develop and implement written policies and procedures regarding a system for maintaining counts of controlled drugs.

(s) Except as required by (t) below, any contaminated, expired, or discontinued medication shall be destroyed within 30 days following the expiration date, the date a licensed practitioner discontinued the order, or the medication becomes contaminated, whichever occurs first.

(t) Destruction of contaminated, expired, or discontinued controlled drugs shall:

(1) Be in accordance with all applicable standards of practice;

(2) Be accomplished in the presence of at least 2 people who shall sign, date, and record the amount destroyed; and

(3) Be documented in the record of the patient for whom the drug was prescribed.

(u) The licensee shall maintain a written record for each medication taken by a patient at the FMTRF that contains the following information:

(1) Any allergies or adverse reactions to medications;

(2) The medication name, strength, dose, frequency, and route of administration;

(3) The date and the time the medication was taken;

(4) The signature, identifiable initials, and job title of the person who administers, supervises, or assists the patient taking medication;

(5) For PRN medications, the reason the patient required the medication, and the effect of the PRN medication; and

(6) Documented reason for any medication refusal or omission.

(v) The facility shall have a written policy that incorporates the requirements listed in (t) through (v) for use in training and for reference by employees supervising medication administration.

(w) The licensee shall report any adverse reactions and side effects to medications or treatments, or any medication or treatment errors, to the patient's licensed practitioner immediately but not to exceed 24 hours depending on the severity of the reaction or error, and shall document in the patient's record the reaction, the error, and date, time, and person notified.

(x) An FMRTF shall have written orders from the licensed practitioner for all medications being taken by patients while under the care of the FMRTF.

Disclaimer: These regulations may not be the most recent version. New Hampshire may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.